Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study.

N Engl J Med. 2007 Jun 28;356(26):2684-92.

2.

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA; National Birth Defects Prevention Study.

BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. Review.

3.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
4.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
5.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
6.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
7.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.

Gentile S.

Acta Psychiatr Scand. 2011 Apr;123(4):266-75. doi: 10.1111/j.1600-0447.2011.01673.x. Epub 2011 Jan 25. Review.

PMID:
21261600
8.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
9.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
10.

[SSRIs and pregnancy: a review of the literature].

Soufia M, Aoun J, Gorsane MA, Krebs MO.

Encephale. 2010 Dec;36(6):513-6. doi: 10.1016/j.encep.2010.02.003. Epub 2010 Apr 3. Review. French.

PMID:
21130237
11.

Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.

Gentile S.

Expert Opin Drug Metab Toxicol. 2015;11(10):1585-97. doi: 10.1517/17425255.2015.1063614. Epub 2015 Jul 1. Review.

PMID:
26135630
12.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
13.

Selective serotonin reuptake inhibitors and malformations: case closed?

Koren G, Nordeng HM.

Semin Fetal Neonatal Med. 2013 Feb;18(1):19-22. doi: 10.1016/j.siny.2012.10.004. Epub 2012 Nov 24. Review.

PMID:
23228547
14.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
15.

Selective serotonin reuptake inhibitors in pregnancy.

Bellissima V, Ververs TF, Visser GH, Gazzolo D.

Curr Med Chem. 2012;19(27):4554-61. Review.

PMID:
22876893
16.

Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.

Myles N, Newall H, Ward H, Large M.

Aust N Z J Psychiatry. 2013 Nov;47(11):1002-12. doi: 10.1177/0004867413492219. Epub 2013 Jun 12. Review.

PMID:
23761574
17.

Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.

Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.

Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. doi: 10.1136/archdischild-2011-214239. Review. Erratum in: Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F180.

PMID:
23080479
18.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
19.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
20.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258

Supplemental Content

Support Center